The role of iron and iron chelators in zygomycosis - Clinical Microbiology and Infection
Iron Chelation Therapy
Efficacy and safety of iron-chelation therapy with deferoxamine, defer | DDDT
Deferoxamine (DFOA) uses, antidote effects, mechanism, indications and ADR's ☠ - YouTube
Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes. - Abstract - Europe PMC
Impact of iron overload on bone remodeling in thalassemia | SpringerLink
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy. - Abstract - Europe PMC
Renal clearable nanochelators for iron overload therapy | Nature Communications
Iron Chelation as a Potential Therapeutic Strategy for AKI Prevention | American Society of Nephrology
View of THERAPEUTIC ADVANCEMENTS IN MANAGEMENT OF IRON OVERLOAD–A REVIEW | International Journal of Pharmacy and Pharmaceutical Sciences
Deferoxamine mesylate improves splicing and GAA activity of the common c.-32-13T>G allele in late-onset PD patient fibroblasts: Molecular Therapy - Methods & Clinical Development
New developments and controversies in iron metabolism and iron chelation therapy
Iron chelation cancer therapy using hydrophilic block copolymers conjugated with deferoxamine - Komoto - 2021 - Cancer Science - Wiley Online Library
Deferoxamine Antidote: 2004
Chelators at the Cancer Coalface: Desferrioxamine to Triapine and Beyond | Clinical Cancer Research
Iron Chelation as a Potential Therapeutic Strategy for AKI Prevention | American Society of Nephrology
Iron Chelators
Iron Chelation and Vascular Function | Arteriosclerosis, Thrombosis, and Vascular Biology
Frontiers | Iron and Alzheimer's Disease: From Pathogenesis to Therapeutic Implications | Neuroscience
Deferasirox in treatment of chronic iron overload - ppt video online download
The Role of Deferiprone in Iron Chelation | NEJM
Treatment of iron overload syndrome: a general review
Deferoxamine - wikidoc
Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes. - Abstract - Europe PMC
